Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Experimental & Molecular Medicine ; : 550-560, 2011.
Article Dans Anglais | WPRIM | ID: wpr-131300

Résumé

Protein arginine methylation is important for a variety of cellular processes including transcriptional regulation, mRNA splicing, DNA repair, nuclear/cytoplasmic shuttling and various signal transduction pathways. However, the role of arginine methylation in protein biosynthesis and the extracellular signals that control arginine methylation are not fully understood. Basic fibroblast growth factor (bFGF) has been identified as a potent stimulator of myofibroblast dedifferentiation into fibroblasts. We demonstrated that symmetric arginine dimethylation of eukaryotic elongation factor 2 (eEF2) is induced by bFGF without the change in the expression level of eEF2 in mouse embryo fibroblast NIH3T3 cells. The eEF2 methylation is preceded by ras-raf-mitogen-activated protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK1/2)-p21(Cip/WAF1) activation, and suppressed by the mitogen-activated protein kinase (MAPK) inhibitor PD98059 and p21(Cip/WAF1) short interfering RNA (siRNA). We determined that protein arginine methyltransferase 7 (PRMT7) is responsible for the methylation, and that PRMT5 acts as a coordinator. Collectively, we demonstrated that eEF2, a key factor involved in protein translational elongation is symmetrically arginine-methylated in a reversible manner, being regulated by bFGF through MAPK signaling pathway.


Sujets)
Animaux , Souris , Arginine , Dédifférenciation cellulaire , Inhibiteur p21 de kinase cycline-dépendante/génétique , Elongation Factor 2 Kinase/métabolisme , Facteur de croissance fibroblastique de type 2/métabolisme , Fibroblastes/métabolisme , Flavonoïdes/pharmacologie , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Méthylation , Mitogen-Activated Protein Kinases/antagonistes et inhibiteurs , Myofibroblastes/anatomopathologie , Cellules NIH 3T3 , Protein Methyltransferases/métabolisme , Protein-arginine N-methyltransferases/métabolisme , Petit ARN interférent/génétique
2.
Experimental & Molecular Medicine ; : 550-560, 2011.
Article Dans Anglais | WPRIM | ID: wpr-131297

Résumé

Protein arginine methylation is important for a variety of cellular processes including transcriptional regulation, mRNA splicing, DNA repair, nuclear/cytoplasmic shuttling and various signal transduction pathways. However, the role of arginine methylation in protein biosynthesis and the extracellular signals that control arginine methylation are not fully understood. Basic fibroblast growth factor (bFGF) has been identified as a potent stimulator of myofibroblast dedifferentiation into fibroblasts. We demonstrated that symmetric arginine dimethylation of eukaryotic elongation factor 2 (eEF2) is induced by bFGF without the change in the expression level of eEF2 in mouse embryo fibroblast NIH3T3 cells. The eEF2 methylation is preceded by ras-raf-mitogen-activated protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK1/2)-p21(Cip/WAF1) activation, and suppressed by the mitogen-activated protein kinase (MAPK) inhibitor PD98059 and p21(Cip/WAF1) short interfering RNA (siRNA). We determined that protein arginine methyltransferase 7 (PRMT7) is responsible for the methylation, and that PRMT5 acts as a coordinator. Collectively, we demonstrated that eEF2, a key factor involved in protein translational elongation is symmetrically arginine-methylated in a reversible manner, being regulated by bFGF through MAPK signaling pathway.


Sujets)
Animaux , Souris , Arginine , Dédifférenciation cellulaire , Inhibiteur p21 de kinase cycline-dépendante/génétique , Elongation Factor 2 Kinase/métabolisme , Facteur de croissance fibroblastique de type 2/métabolisme , Fibroblastes/métabolisme , Flavonoïdes/pharmacologie , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Méthylation , Mitogen-Activated Protein Kinases/antagonistes et inhibiteurs , Myofibroblastes/anatomopathologie , Cellules NIH 3T3 , Protein Methyltransferases/métabolisme , Protein-arginine N-methyltransferases/métabolisme , Petit ARN interférent/génétique
SÉLECTION CITATIONS
Détails de la recherche